Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces First Patients Treated in Phase 2 Study of Focal One for the Treatment of Deep Invasive Endometriosis
       ·  First patients already treated as recruitment accelerates LYON, France , September 3, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first two patients have been treated in the company’s Phase 2 clinical trial assessing
View HTML
Toggle Summary EDAP Reports Second Quarter 2020 Results and Provides Operational Update
Completed multiple Focal One sales to renowned U.S. and international health care institutions, including multiple Focal One™-ExactVu™ bundled sales Announced first two U.S. publications in Journal of Urology detailing positive outcomes from U.S. studies of HIFU for the successful partial-gland
View HTML
Toggle Summary EDAP Announces Approval for Phase II Study Evaluating High Intensity Focused Ultrasound (HIFU) for Deep Invasive Endometriosis
Multicenter study to commence in September in France Reinforces company’s recent shift in strategic focus toward development of additional high-value HIFU tissue ablation indications LYON, France , August 25, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic
View HTML
Toggle Summary EDAP TMS SA to Announce Second Quarter 2020 Financial Results on August 26, 2020
Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDT LYON, France , August 19, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter ended June 30, 2020 after the
View HTML
Toggle Summary EDAP Announces Two Publications Highlighting Favorable HIFU Focal Therapy Outcomes in Journal of Urology
  Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ultrasound therapy to treat prostate cancer patients since FDA cleared the technology in 2015.
View HTML
Toggle Summary EDAP Announces Recent Focal One Sales Successes
Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solution Company recorded an additional three stand-alone ExactVu purchase orders at major centers LYON, France , July 15, 2020 -- EDAP TMS SA (Nasdaq:
View HTML
Toggle Summary EDAP Appoints Medical Technology Executive Marie Meynadier to its Board of Directors
  Appointment adds significant medical technology executive and board leadership experience LYON, France , June 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today that veteran medical technology executive Marie Meynadier has
View HTML
Toggle Summary EDAP Appoints Frank Van Hyfte as Vice President of Global Sales and Marketing
Seasoned medical technology sales and marketing professional brings more than 25 years of experience to the EDAP team Joins EDAP from Exact Imaging to lead the recently announced global distribution agreement between the two companies LYON, France , May 28, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the
View HTML
Toggle Summary EDAP Reports First Quarter 2020 Results and Provides Operational Update
Maintains strong balance sheet with EUR 18.5 million ( USD 20.3 million ) in cash as of March 31, 2020 Signs exclusive worldwide distribution agreement with Exact Imaging to combine their innovative micro-ultrasound technology with Focal One to offer an end-to-end focal therapy solution for the
View HTML
Toggle Summary EDAP ANNOUNCES EXCLUSIVE WORLDWIDE DISTRIBUTION RIGHTS TO EXACT IMAGING’S MICRO-ULTRASOUND TECHNOLOGIES
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s
View HTML